Repurposing Artemisinin-Based Drugs from Antimalarial to Pan-Therapeutic: Pharmacological Promise and Therapeutic Challenges

Abstract The sourcing of pharmaceutical agents from natural products remains a cornerstone of drug discovery. For millennia, herbal remedies have served as foundational therapeutic interventions, yet their mechanisms of action often remain elusive. Artemisinin (ART, or “Qinghaosu”) and its derivatives, collectively known as ARTs, exemplify this paradigm. Originating from traditional Chinese medicine, these well-established antimalarial compounds exhibit potent cytotoxicity, positioning them as promising anti-cancer agents. ARTs operate through multiple cancer cell-intrinsic mechanisms and demonstrate synergistic effects with conventional therapies, even against chemoresistant malignancies. Beyond oncology, the therapeutic portfolio of ART-based drugs is rapidly expanding. This review synthesizes recent advancements in the application of ARTs for treating various cancers, Alzheimer’s disease, and reproductive disorders. Furthermore, we explore the frontier of ART drug development, focusing on the rational design of ART-derived molecular hybrids and the engineering of nano-enabled delivery systems. These innovative strategies are pivotal for enhancing anti-cancer efficacy and achieving cancer-specific targeting. Ultimately, this work aims to guide the innovation of ART-based precision medicine, revitalizing the exploration and development of natural products in modern pharmacotherapy.

• Publication year

  2025

• Venue

  Drug Design, Development and Therapy

• Publication date

  2025-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2147/DDDT.S545163PMID 41104396PMCID 12526406
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Artesunate-multiple pharmacological effects beyond treating malaria.

  2025cited by this paper
• Artesunate Nanoplatform Targets the Serine–MAPK Axis in Cancer‐Associated Fibroblasts to Reverse Photothermal Resistance in Triple‐Negative Breast Cancer

  2025cited by this paper
• A comprehensive review on signaling attributes of serine and serine metabolism in health and disease.

  2024cited by this paper
• Rhizoma Alismatis Decoction improved mitochondrial dysfunction to alleviate SASP by enhancing autophagy flux and apoptosis in hyperlipidemia acute pancreatitis.

  2024cited by this paper
• Dihydroartemisinin-driven selective anti-lung cancer proliferation by binding to EGFR and inhibition of NRAS signaling pathway-induced DNA damage

  2024cited by this paper
• Enhancement of gemcitabine sensitivity in intrahepatic cholangiocarcinoma through Saikosaponin-a mediated modulation of the p-AKT/BCL-6/ABCA1 axis.

  2024cited by this paper
• Mechanistic and therapeutic perspectives of miRNA-PTEN signaling axis in cancer therapy resistance.

  2024cited by this paper
• A pH and glutathione-responsive carbon monoxide-driven nano-herb delivery system for enhanced immunotherapy in colorectal cancer.

  2024cited by this paper
• Regulation of Dihydroartemisinin on the pathological progression of laryngeal carcinoma through the periostin/YAP/IL-6 pathway

  2024influential reference
• GLUT and HK: two primary and essential key players in Tumor glycolysis.

  2024cited by this paper
• Tuning pH-dependent cytotoxicity in cancer cells by peripheral fluorine substitution on pseudopeptidic cages

  2024cited by this paper
• β-Lapachone, an NQO1 bioactivatable drug, prevents lung tumorigenesis in mice.

  2024cited by this paper
• 2-Monoacylglycerol Mimetic Liposomes to Promote Intestinal Lymphatic Transport for Improving Oral Bioavailability of Dihydroartemisinin

  2024cited by this paper
• Dihydroartemisinin inhibits HNSCC invasion and migration by controlling miR-195-5p expression

  2024cited by this paper
• pH and ROS Dual‐Responsive Autocatalytic Release System Potentiates Immunotherapy of Colorectal Cancer

  2024cited by this paper
• Biomineralized apoferritin nanoparticles delivering dihydroartemisinin and calcium for synergistic breast cancer therapy

  2024cited by this paper
• A new tau dephosphorylation-targeting chimera for the treatment of tauopathies

  2024cited by this paper
• PARD3 drives tumorigenesis through activating Sonic Hedgehog signalling in tumour-initiating cells in liver cancer

  2024cited by this paper
• Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interaction

  2024cited by this paper
• Acidic Environment-Responsive Metal Organic Framework-Mediated Dihydroartemisinin Delivery for Triggering Production of Reactive Oxygen Species in Drug-Resistant Lung Cancer

  2024cited by this paper
• Glioma

  2024cited by this paper
• Another Use for a Proven Drug: Experimental Evidence for the Potential of Artemisinin and Its Derivatives to Treat Alzheimer’s Disease

  2024cited by this paper
• Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations

  2024cited by this paper
• Dihydroartemisinin Sensitizes Lung Cancer Cells to Cisplatin Treatment by Upregulating ZIP14 Expression and Inducing Ferroptosis

  2024cited by this paper
• A gold cluster fused manganese dioxide nanocube loaded with dihydroartemisinin for effective cancer treatment via amplified oxidative stress

  2024cited by this paper
• Artemisia annua L. Polyphenols Enhance the Anticancer Effect of β-Lapachone in Oxaliplatin-Resistant HCT116 Colorectal Cancer Cells

  2023cited by this paper
• Targeting the AKT‐P53/CREB pathway with epicatechin for improved prognosis of traumatic brain injury

  2023cited by this paper
• Retinoic acid signaling in development and differentiation commitment and its regulatory topology.

  2023cited by this paper
• Pancreatic cancer: Advances and challenges

  2023cited by this paper
• A mitochondria-targeting dihydroartemisinin derivative as a reactive oxygen species -based immunogenic cell death inducer

  2023cited by this paper
• Targeting HSP70 chaperones by rhein sensitizes liver cancer to artemisinin derivatives.

  2023cited by this paper
• The molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and disease

  2023cited by this paper
• Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models

  2023cited by this paper
• Biology and therapeutic targeting of vascular endothelial growth factor A

  2023cited by this paper
• Neuroprotective Strategies for Stroke by Natural Products: Advances and Perspectives

  2023cited by this paper
• Low-temperature photothermal-induced alkyl radical release facilitates dihydroartemisinin-triggered “valve-off” starvation therapy

  2023cited by this paper
• In Situ Vaccination with Mitochondria‐Targeting Immunogenic Death Inducer Elicits CD8+ T Cell‐Dependent Antitumor Immunity to Boost Tumor Immunotherapy

  2023cited by this paper
• How I treat refractory and relapsed acute myeloid leukemia.

  2023cited by this paper
• Activated AMPK mitigates diabetes-related cognitive dysfunction by inhibiting hippocampal ferroptosis.

  2023cited by this paper
• Biomedical applications of MnO2 nanomaterials as nanozyme-based theranostics.

  2023cited by this paper
• Periostin secreted from podoplanin‐positive cancer‐associated fibroblasts promotes metastasis of gastric cancer by regulating cancer stem cells via AKT and YAP signaling pathway

  2023cited by this paper
• Pushen capsule treatment promotes functional recovery after ischemic stroke.

  2023cited by this paper
• Angiogenic signaling pathways and anti-angiogenic therapy for cancer

  2023cited by this paper
• A whole‐genome scan for Artemisinin cytotoxicity reveals a novel therapy for human brain tumors

  2023cited by this paper
• Artemisia annua Extract Improves the Cognitive Deficits and Reverses the Pathological Changes of Alzheimer’s Disease via Regulating YAP Signaling

  2023influential reference
• Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier

  2023cited by this paper
• Polyaspartic Acid-Stabilized CaCO3-Containing In Situ Hydrogel for Protection and Treatment of Gastric Ulcer.

  2023cited by this paper
• Dihydroartemisinin Induced Apoptosis and Synergized With Chemotherapy in Pleural Effusion Lymphoma Cells

  2023cited by this paper
• Metal-organic framework-encapsulated dihydroartemisinin nanoparticles induces apoptotic cell death in ovarian cancer by blocking ROMO1-mediated ROS production

  2023cited by this paper
• Mechanistic and therapeutic role of NLRP3 inflammasome in the pathogenesis of Alzheimer's disease

  2023cited by this paper
• Dihydroartemisinin elicits immunogenic death through ferroptosis-triggered ER stress and DNA damage for lung cancer immunotherapy.

  2023cited by this paper
• Ferroptosis: A flexible constellation of related biochemical mechanisms.

  2023cited by this paper
• pH-Responsive Hydrogel as a Potential Oral Delivery System of Baicalin for Prolonging Gastroprotective Activity

  2023cited by this paper
• Active post-transcriptional regulation and ACLY-mediated acetyl-CoA synthesis as a pivotal target of Shuang-Huang-Sheng-Bai formula for lung adenocarcinoma treatment.

  2023cited by this paper
• Artemisinin exerts a protective effect in the MPTP mouse model of Parkinson's disease by inhibiting microglial activation via the TLR4/Myd88/NF‐KB pathway

  2023cited by this paper
• Macrophages in immunoregulation and therapeutics

  2023cited by this paper
• Glabridin inhibits liver fibrosis and hepatic stellate cells activation through suppression of inflammation and oxidative stress by activating PPARγ in carbon tetrachloride-treated mice.

  2022cited by this paper
• Modulating Chaperone-Mediated Autophagy and Its Clinical Applications in Cancer

  2022cited by this paper
• Artesunate restores mitochondrial fusion‐fission dynamics and alleviates neuronal injury in Alzheimer's disease models

  2022cited by this paper
• Regional Aβ-tau interactions promote onset and acceleration of Alzheimer's disease tau spreading.

  2022cited by this paper
• Artemisinin Attenuates Amyloid-Induced Brain Inflammation and Memory Impairments by Modulating TLR4/NF-κB Signaling

  2022cited by this paper
• Effect and mechanism of paclitaxel loaded on magnetic Fe3O4@mSiO2-NH2-FA nanocomposites to MCF-7 cells

  2022cited by this paper
• Identification of Novel Artemisinin Hybrids Induce Apoptosis and Ferroptosis in MCF-7 Cells

  2022cited by this paper
• Artesunate, a new antimalarial clinical drug, exhibits potent anti‐AML activity by targeting the ROS/Bim and TFRC/Fe2+ pathways

  2022cited by this paper
• The Anti-Breast Cancer Activity of Dihydroartemisinin-5-methylisatin Hybrids Tethered via Different Carbon Spacers

  2022cited by this paper
• Role of Microglia and Astrocytes in Alzheimer’s Disease: From Neuroinflammation to Ca2+ Homeostasis Dysregulation

  2022cited by this paper
• Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis

  2022cited by this paper
• Effect of malaria and malaria chemoprevention regimens in pregnancy and childhood on neurodevelopmental and behavioral outcomes in children at 12, 24 and 36 months: a randomized clinical trial.

  2022cited by this paper
• Dihydroartemisinin Reduces Irradiation-Induced Mitophagy and Radioresistance in Lung Cancer A549 Cells via CIRBP Inhibition

  2022cited by this paper
• Dihydroartemisinin remodels macrophage into an M1 phenotype via ferroptosis-mediated DNA damage

  2022cited by this paper
• Emerging Small Molecule-Engineered Hybrid Nanomedicines for Cancer Therapy

  2022cited by this paper
• Novel nitrogen mustard-artemisinin hybrids with potent anti-leukemia action through DNA damage and activation of GPx.

  2022cited by this paper
• Inflammation: the incubator of the tumor microenvironment.

  2022cited by this paper
• Synergistic effects of two naturally occurring iridoids in eliciting a rapid antidepressant action by up‐regulating hippocampal PACAP signalling

  2022cited by this paper
• Targeted xCT‐mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti‐PD‐1/L1 Response

  2022cited by this paper
• Classical RAS proteins are not essential for paradoxical ERK activation induced by RAF inhibitors

  2022cited by this paper
• Tumour-associated neutrophils secrete AGR2 to promote colorectal cancer metastasis via its receptor CD98hc–xCT

  2022cited by this paper
• A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin

  2022influential reference
• Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements

  2022cited by this paper
• Programmed death ligand 1 signals in cancer cells

  2022cited by this paper
• DHA Ameliorates Cognitive Ability, Reduces Amyloid Deposition, and Nerve Fiber Production in Alzheimer’s Disease

  2022cited by this paper
• Influence of amyloid-β on tau spread in Alzheimer disease explained

  2022cited by this paper
• Cell death mechanisms induced by synergistic effects of halofuginone and artemisinin in colorectal cancer cells

  2022influential reference
• Redox Dyshomeostasis with Dual Stimuli‐Activatable Dihydroartemisinin Nanoparticles to Potentiate Ferroptotic Therapy of Pancreatic Cancer

  2022cited by this paper
• Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy by inhibiting GPX4 and enhancing ROS.

  2022cited by this paper
• Forsythoside B attenuates neuro-inflammation and neuronal apoptosis by inhibition of NF-κB and p38-MAPK signaling pathways through activating Nrf2 post spinal cord injury.

  2022cited by this paper
• Sinomenine Confers Protection Against Myocardial Ischemia Reperfusion Injury by Preventing Oxidative Stress, Cellular Apoptosis, and Inflammation

  2022cited by this paper
• Rhein Suppresses Colorectal Cancer Cell Growth by Inhibiting the mTOR Pathway In Vitro and In Vivo

  2021cited by this paper
• Incomplete radiofrequency ablation induced chemoresistance by up-regulating heat shock protein 70 in hepatocellular carcinoma.

  2021cited by this paper
• Nano‐enabled Tumor Systematic Energy Exhaustion via Zinc (II) Interference Mediated Glycolysis Inhibition and Specific GLUT1 Depletion

  2021cited by this paper
• Baicalin Prevents Myocardial Ischemia/Reperfusion Injury Through Inhibiting ACSL4 Mediated Ferroptosis

  2021cited by this paper
• Pharmacological Actions of Myricetin in the Nervous System: A Comprehensive Review of Preclinical Studies in Animals and Cell Models

  2021cited by this paper
• Leukaemia: a model metastatic disease

  2021cited by this paper
• Dihydroartemisinin inhibits IL-6-induced epithelial–mesenchymal transition in laryngeal squamous cell carcinoma via the miR-130b-3p/STAT3/β-catenin signaling pathway

  2021cited by this paper
• Alpinetin exerts anti-inflammatory, anti-oxidative and anti-angiogenic effects through activating the Nrf2 pathway and inhibiting NLRP3 pathway in carbon tetrachloride-induced liver fibrosis.

  2021cited by this paper
• Head and neck cancer

  2021cited by this paper
• 1,3,4-Oxadiazole-containing hybrids as potential anticancer agents: Recent developments, mechanism of action and structure-activity relationships

  2021cited by this paper
• Targeted Lipid Nanoparticles Encapsulating Dihydroartemisinin and Chloroquine Phosphate for Suppressing the Proliferation and Liver Metastasis of Colorectal Cancer

  2021cited by this paper
• The Many Faces of Astrocytes in Alzheimer's Disease

  2021cited by this paper
• NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.

  2021cited by this paper

• No citing papers are available for this paper.